global
travel
trade
chang
demograph
land
use
climat
chang
usher
era
wherein
viral
hemorrhag
fever
respiratori
viru
pandem
longer
obscur
popular
media
focus
attent
biodefens
emerg
infecti
diseas
provid
foundat
unpreced
support
basic
translat
research
host
vector
microb
biolog
well
diagnost
surveil
vaccin
therapeut
new
molecular
technolog
masstag
polymeras
chain
reaction
pcr
microbi
microarray
unbias
high
throughput
pyrosequenc
facilit
effici
differenti
diagnosi
infecti
diseas
well
pathogen
surveil
discoveri
databas
need
recogn
sequenc
host
microbi
improv
dramat
appreci
emerg
infecti
diseas
repres
zoonos
also
impact
address
issu
sampl
collect
need
proactiv
address
infect
wildlif
domest
anim
vector
well
human
examin
bush
meat
promot
surveil
region
defin
model
hot
spot
infecti
diseas
emerg
advent
countermeasur
tailor
specif
virus
includ
small
molecul
rnai
therapeut
antibodi
vaccin
accur
earli
differenti
diagnosi
viral
infect
increasingli
import
clinic
medicin
well
public
health
treatment
decis
must
frequent
balanc
potenti
benefit
potenti
toxic
antivir
therapi
toxic
minim
suppli
limit
may
nonetheless
imper
drug
reserv
case
effect
final
treatment
frequent
effect
earli
cours
viral
burden
lower
import
appreci
agent
virus
caus
hemorrhag
fever
one
recent
exampl
individu
succumb
acut
febril
ill
failur
outbreak
marburg
hemorrhag
fever
ultim
found
panmicrobi
microarray
analysi
malaria
effect
antimalari
therapi
might
institut
appropri
diagnosi
establish
earlier
time
point
find
footprint
organ
first
step
establish
causal
relationship
understand
caus
diseas
nonetheless
viral
hemorrhag
fever
continu
discoveri
process
implic
candid
typic
straightforward
diseas
acut
agent
present
high
level
affect
tissu
time
diseas
manifest
morpholog
chang
consist
infect
evid
classic
molecular
method
isol
character
commonli
success
frequent
evid
adapt
immun
respons
thu
even
one
anim
model
requir
formal
meet
bar
proof
causat
establish
koch
loeffler
agent
present
everi
case
diseas
specif
diseas
propag
cultur
inocul
host
caus
diseas
strong
candid
rare
controversi
review
one
typic
focu
latest
molecular
technolog
nonetheless
import
recogn
pivot
role
clinic
acumen
patholog
serolog
classic
cultur
techniqu
clinician
epidemiologist
unherald
hero
front
line
pathogen
discoveri
appreci
appear
anomali
collect
materi
investig
persuad
laboratori
colleagu
invest
search
known
novel
pathogen
anatom
patholog
join
immunohistochemistri
instrument
direct
molecular
work
investig
exploit
properti
antisera
reveal
presenc
agent
relat
alreadi
known
although
larg
panel
antisera
requir
type
work
restrict
highli
special
research
center
potenc
approach
underscor
fact
discoveri
sin
nombr
viru
nipah
viru
west
nile
viru
lujo
viru
facilit
demonstr
viral
protein
tissu
turn
allow
focus
consensu
pcr
analys
method
tissu
cultur
serolog
also
import
tissu
cultur
pivot
sar
outbreak
wherein
growth
viru
enabl
rapid
character
use
consensu
pcr
random
prime
cdna
librari
microarray
electron
microscopi
sinc
advent
pcr
method
clone
microbi
nucleic
acid
directli
clinic
specimen
becom
commonplac
pathogen
surveil
discoveri
past
two
decad
subtract
clone
express
clone
consensu
pcr
high
throughput
pyrosequenc
result
identif
novel
agent
associ
acut
chronic
diseas
includ
borna
diseas
viru
hepat
c
viru
sin
nombr
viru
bartonella
hensela
tropheryma
whippelii
nipah
viru
sar
coronaviru
israel
acut
paralysi
viru
avian
borna
viru
lujo
viru
clinic
microbiolog
singleplex
pcr
assay
increasingli
implement
detect
quantit
burden
individu
candid
organ
assay
revolution
blood
bank
manag
hiv
helpat
c
viru
enabl
contain
outbreak
infecti
diseas
degener
primer
employ
singleplex
pcr
assay
reduc
stringenc
facilit
detect
relat
unknown
organ
howev
clinic
manifest
typic
pathognomon
infect
specif
pathogen
thu
unless
investig
clue
patholog
serolog
use
focu
search
cumbersom
strategi
even
sampl
resourc
time
suffici
invest
mani
singleplex
assay
differ
agent
multiplex
assay
howev
allow
investig
test
mani
hypothes
parallel
number
candid
consid
assay
rang
less
multiplex
pcr
thousand
microarray
entir
tree
life
unbias
high
throughput
sequenc
although
context
outbreak
time
essenc
pursu
sever
method
simultan
less
urgent
situat
tri
contain
cost
pathogen
discoveri
stage
invest
frequent
epidemiolog
serolog
patholog
suggest
one
candid
allow
use
consensu
pcr
degener
primer
clue
known
assay
singl
agent
fail
syndrom
multiplex
pcr
assay
use
test
sever
candid
simultan
multiplex
assay
distinguish
product
size
continu
use
howev
assay
labor
intens
less
sensit
assay
base
fluoresc
report
dye
mass
spectrometr
analys
autom
enabl
high
throughput
sensit
approach
singleplex
pcr
fluoresc
assay
take
sever
form
fluoresc
report
dye
attach
primer
scorpion
premier
biosoft
palo
alto
ca
other
intermedi
label
oligonucleotid
cleav
taqman
appli
biosystem
inc
foster
citi
ca
hybrid
molecular
beacon
separ
excitatori
quencher
moieti
anoth
amplif
product
bind
label
bead
luminex
corpor
austin
tx
two
multiplex
platform
develop
combin
pcr
mass
spectroscopi
ms
sensit
detect
sever
target
simultan
one
triangul
identif
genet
evalu
risk
tiger
use
laser
desorptionion
maldi
ms
directli
measur
molecular
weight
pcr
product
obtain
experiment
sampl
compar
databas
known
predict
product
weight
masstag
pcr
use
atmospher
pressur
chemic
ioniz
apci
ms
read
photocleav
molecular
weight
report
tag
attach
pcr
primer
microarray
may
help
appropri
multiplex
panel
establish
multiplex
pcr
fail
howev
sensit
lower
multiplex
pcr
method
viral
microarray
coars
divid
address
agent
design
detect
thousand
agent
includ
unknown
array
design
address
limit
number
agent
exampl
respiratori
viru
resequenc
array
may
employ
multiplex
consensu
pcr
amplifi
specif
genet
target
although
array
typic
employ
probe
less
nt
may
allow
speciat
agent
truli
exploit
util
microarray
unbias
microb
detect
oligonucleotid
microarray
compris
hundr
thousand
featur
probe
nt
uncommon
thu
unlik
pcr
resequenc
array
short
primer
sequenc
demand
precis
complementar
probe
target
array
less
like
confound
minor
sequenc
variat
consider
advantag
detect
rapidli
evolv
target
rna
virus
addit
one
incorpor
microbi
host
gene
target
array
afford
opportun
detect
microb
assess
host
respons
signatur
consist
variou
class
infecti
agent
viral
array
facilit
clone
sequenc
analysi
well
pathogen
identif
follow
random
amplif
protocol
hybrid
product
typic
rang
nt
nt
array
display
probe
repres
sever
differ
genom
region
viru
one
rapidli
recov
sequenc
elut
hybrid
product
also
sequenc
product
use
pcr
amplif
classic
sensit
major
challeng
array
technolog
also
appli
unbias
high
throughput
sequenc
rest
amplif
step
amplifi
host
microbi
sequenc
similar
effici
acellular
sampl
serum
tissu
cultur
medium
issu
host
nucleic
acid
minim
howev
tissu
host
nucleic
acid
like
domin
chromosom
dna
elimin
dnase
digest
howev
ribosom
rna
difficult
address
seen
modest
improv
sensit
rrna
captur
digest
mutliplex
pcr
method
lesser
extent
microarray
requir
agent
close
relat
one
alreadi
known
agent
suffici
distant
sequenc
confound
hybrid
primer
probe
may
still
identifi
unbias
high
throughput
sequenc
depend
platform
employ
strategi
yield
sequenc
fragment
typic
rang
size
nt
fragment
use
queri
databas
similar
sequenc
repres
host
microb
definit
truli
novel
repres
databas
howev
abl
detect
similar
aa
level
suffici
genu
level
identif
detect
nt
level
even
agent
identifi
use
less
expens
labor
intens
method
unbias
high
throughput
sequenc
may
employ
approach
elimin
time
consum
clone
prior
sequenc
need
classic
dideoxi
method
exampl
bundibugyo
viru
new
ebolaviru
speci
associ
recent
hemorrhag
fever
outbreak
uganda
discov
use
convent
method
genet
character
pyrosequenc
subtract
clone
may
succeed
unbias
high
throughput
sequenc
fail
borna
diseas
viru
exampl
first
agent
discov
unbias
molecular
method
would
found
consensu
pcr
microarray
high
throughput
sequenc
genom
sequenc
dissimilar
agent
new
analyt
model
base
neurolinguist
cryptographi
may
facilit
recognit
microbi
sequenc
even
lack
similar
known
microb
primari
sequenc
level
mani
tool
describ
chapter
avail
special
laboratori
industri
world
unlik
full
complement
technolog
broadli
distribut
near
futur
essenti
capac
differenti
diagnosi
infecti
diseas
establish
develop
world
risk
burden
hemorrhag
fever
promin
toward
end
encourag
academician
public
health
practition
corpor
partner
begin
focu
smaller
footprint
solut
phase
microarray
platform
promis
perform
environ
invest
surveil
bush
meat
wildlif
domest
anim
human
geograph
hot
spot
increas
risk
emerg
infecti
diseas
emerg
long
overdu
encourag
recent
increas
support
proactiv
effort
author
declar
conflict
interest
